The British Journal of Cancer (BJC) is a leading international journal dedicated to publishing high-impact research across the breadth of cancer research. With a firm commitment to accelerating progress in the fight against cancer, the BJC provides a platform for disseminating cutting-edge discoveries, innovative approaches, and translational findings that have the potential to improve patient outcomes. It focuses on investigations spanning from basic science to clinical application, including studies on cancer biology, genetics, immunology, drug discovery, and clinical trials.
Key areas covered include oncology, clinical oncology, clinical medicine, cancer prevention, early detection, diagnosis, and treatment. The journal prioritizes studies that address major challenges in cancer research, such as drug resistance, metastasis, and personalized medicine. Regularly indexed in leading databases, including CAS, Scopus, and Web of Science, the BJC ensures wide dissemination of its content.
With its broad scope and commitment to excellence, the BJC serves as an indispensable resource for researchers, clinicians, and policymakers working to conquer cancer. Explore innovative research on cancer and its treatments. Submit your manuscript today!